Compare Heron Therapeutics Inc (HRTX) vs Shopify Inc. (SHOP) Price & Performance

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

SHOP trades at $125.88, up 1.88% today, with a bullish technical signal from moving averages. The stock shows strong revenue growth, reaching $11.56 billion in 2025, and has turned profitable with a net income margin of 10.77%. Recent news highlights its AI strategy and a Jefferies upgrade to Buy with a $160 target. Cash flow from operations improved to $2.03 billion, though valuation ratios remain elevated.

The outlook is positive, supported by analyst consensus and growth in AI-driven commerce. However, high P/E of 121.14 and competitive pressures from Amazon pose risks. Upside to the $150.08 consensus target depends on execution of AI initiatives and sustained profitability.